“Behavioral/Mental Health Care Software & Services Market Report is set to have rapid growth due the increasing adoption of BHS, availability of government funding, and government initiatives to encourage EHR adoption in behavioral health organizations at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report
04 September 2019
Visiongain has launched a new pharma report Behavioral/Mental Health Care Software & Services Market Forecast 2019-2029: By Component, By Delivery Model, By Function, By End Use, By Region, And Segment Forecasts
The global Behavioral/Mental Health Care Software & Services market is poised for rapid growth between 2019 and 2029. The market is likely to experience growth opportunities in software behavioral health in emerging markets and a growing emphasis on subscription models.
In 2014, approximately 21.5 million people in the United States were affected by substance abuse disorders. Of these, only 2.5 million people have actually received treatment. Therefore, there is a large margin for improving the performance of behavioral health care. According to the US Department of Health and Human Services, the health budget for substance abuse treatment services was estimated at around $ 35 billion in 2014.
With the increasing burden of depression and stress due to working or personal life, the adoption rate of an EHR system is increasing. It has also been noted that over time, specialized healthcare providers, including mental and behavioral health providers, have begun to request electronic medical records (EHRs) that have been designed specifically for their needs.
Leading companies featured in the report include Cerner Corporation; Core solutions, Inc.; Epic; Netsmart Technologies; Welligent, Inc.; and others
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The antibiotics market was valued at US$44,567.3 million in 2022 and is projected to grow at a CAGR of 4.15% during the forecast period 2023-2033.
31 January 2023
The global Clinical Trial Supplies market was valued at US$ 2,617.7 million in 2022 and is projected to grow at a CAGR of 9.32% during the forecast period 2023-2033.
31 January 2023
The global Meningococcal Vaccines market was valued at US$3,268.6 million in 2022 and is projected to grow at a CAGR of 6.32% during the forecast period 2023-2033.
31 January 2023
The global Human Microbiome market was valued at US$186.8 million in 2022 and is projected to grow at a CAGR of 25% during the forecast period 2023-2033.